161 related articles for article (PubMed ID: 38254878)
1. Galactosylceramide Upregulates the Expression of the
Suchanski J; Reza S; Urbaniak A; Woldanska W; Kocbach B; Ugorski M
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254878
[TBL] [Abstract][Full Text] [Related]
2. Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule.
Owczarek TB; Suchanski J; Pula B; Kmiecik AM; Chadalski M; Jethon A; Dziegiel P; Ugorski M
PLoS One; 2013; 8(12):e84191. PubMed ID: 24391908
[TBL] [Abstract][Full Text] [Related]
3. Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression.
Suchanski J; Grzegrzolka J; Owczarek T; Pasikowski P; Piotrowska A; Kocbach B; Nowak A; Dziegiel P; Wojnar A; Ugorski M
Breast Cancer Res; 2018 Nov; 20(1):133. PubMed ID: 30400820
[TBL] [Abstract][Full Text] [Related]
4. Herbal Melanin Inhibits Real-Time Cell Proliferation, Downregulates Anti-Apoptotic Proteins and Upregulates Pro-Apoptotic p53 Expression in MDA-MB-231 and HCT-116 Cancer Cell Lines.
Rajabathar JR; Al-Lohedan H; Arokiyaraj S; Mohammed F; Al-Dhayan DM; Faqihi NA; Al-Saigh H
Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138165
[No Abstract] [Full Text] [Related]
5. Withania
Maarouf RE; Azab KS; El Fatih NM; Helal H; Rashed L
Hum Exp Toxicol; 2023; 42():9603271231180849. PubMed ID: 37294601
[TBL] [Abstract][Full Text] [Related]
6. Enzalutamide Overcomes Dihydrotestosterone-Induced Chemoresistance in Triple- Negative Breast Cancer Cells
Alsawalha L; Ahram M; Abdullah MS; Dalmizrak O
Anticancer Agents Med Chem; 2022; 22(17):3038-3048. PubMed ID: 35579133
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative potentials of
Saravanan S; Hari R; Sekar K
Avicenna J Med Biotechnol; 2023; 15(3):188-195. PubMed ID: 37538242
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis induction in human breast cancer cell lines by synergic effect of raloxifene and resveratrol through increasing proapoptotic genes.
Mirzapur P; Khazaei MR; Moradi MT; Khazaei M
Life Sci; 2018 Jul; 205():45-53. PubMed ID: 29705353
[TBL] [Abstract][Full Text] [Related]
9. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
[TBL] [Abstract][Full Text] [Related]
10. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells.
Ghiasi N; Habibagahi M; Rosli R; Ghaderi A; Yusoff K; Hosseini A; Abdullah S; Jaberipour M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6605-11. PubMed ID: 24377575
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells.
Singh B; Cook KR; Vincent L; Hall CS; Berry JA; Multani AS; Lucci A
J Surg Res; 2008 Jun; 147(2):240-6. PubMed ID: 18498876
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor SOX3 upregulated pro-apoptotic genes expression in human breast cancer.
Silva FHS; Underwood A; Almeida CP; Ribeiro TS; Souza-Fagundes EM; Martins AS; Eliezeck M; Guatimosim S; Andrade LO; Rezende L; Gomes HW; Oliveira CA; Rodrigues RC; Borges IT; Cassali GD; Ferreira E; Del Puerto HL
Med Oncol; 2022 Sep; 39(12):212. PubMed ID: 36175695
[TBL] [Abstract][Full Text] [Related]
13. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide.
Simões-Wüst AP; Schürpf T; Hall J; Stahel RA; Zangemeister-Wittke U
Breast Cancer Res Treat; 2002 Nov; 76(2):157-66. PubMed ID: 12452453
[TBL] [Abstract][Full Text] [Related]
15. Bcl2-negative MCF7 cells overexpress p53: implications for the cell cycle and sensitivity to cytotoxic drugs.
Poliseno L; Mariani L; Collecchi P; Piras A; Zaccaro L; Rainaldi G
Cancer Chemother Pharmacol; 2002 Aug; 50(2):127-30. PubMed ID: 12172977
[TBL] [Abstract][Full Text] [Related]
16. Nitric Oxide Synthase Potentiates the Resistance of Cancer Cell Lines to Anticancer Chemotherapeutics.
Barnawi I; Hawsawi YM; Dash P; Oyouni AAA; Mustafa SK; Hussien NA; Al-Amer O; Alomar S; Mansour L
Anticancer Agents Med Chem; 2022; 22(7):1397-1406. PubMed ID: 34165414
[TBL] [Abstract][Full Text] [Related]
17. Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells.
Dewidar SA; Hamdy O; Soliman MM; El Gayar AM; El-Mesery M
Med Oncol; 2023 Dec; 41(1):7. PubMed ID: 38051378
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor positive breast tumors resist chemotherapy by the overexpression of P53 in Cancer Stem Cells.
Ashour F; Awwad MH; Sharawy HEL; Kamal M
J Egypt Natl Canc Inst; 2018 Jun; 30(2):45-48. PubMed ID: 29779937
[TBL] [Abstract][Full Text] [Related]
19. Studies on the relationship between estrogen receptor content, glutathione S-transferase pi expression, and induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and drug resistance in human breast cancer cells.
Hoivik D; Wilson C; Wang W; Willett K; Barhoumi R; Burghardt R; Safe S
Arch Biochem Biophys; 1997 Dec; 348(1):174-82. PubMed ID: 9390189
[TBL] [Abstract][Full Text] [Related]
20. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.
Zhang HY; Liang F; Zhang JW; Wang F; Wang L; Kang XG
Cancer Chemother Pharmacol; 2017 Feb; 79(2):327-337. PubMed ID: 28063065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
